|
🐜
|
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
22 auth.
Xin Xu,
Jian Sun,
S. Nie,
Huiyuan Li,
Y. Kong,
M. Liang,
J. Hou,
Xianzhong Huang,
Dongfeng Li,
Tean Ma,
...
Jiaqing Peng,
Shikui Gao,
Y. Shao,
Hong-Bo Zhu,
J. Lau,
Guangyu Wang,
Chunbao Xie,
Li Jiang,
A. Huang,
Zhenglin Yang,
Kang Zhang,
F. Hou
|
8 |
2020 |
8
🐜
|
|
🐜
|
Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
19 auth.
J. Hou,
Guiqiang Wang,
Fusheng Wang,
Jun Cheng,
H. Ren,
Z. Hui,
Jian Sun,
Lanjuan Li,
Jie Li,
Q. Meng,
...
Jingmin Zhao,
Z. Duan,
J. Jia,
Hong Tang,
J. Sheng,
Jie Peng,
F. Lu,
Q. Xie,
Lai Wei
|
8 |
2017 |
8
🐜
|
|
🐜
|
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
42 auth.
R. Fan,
G. Papatheodoridis,
Jian Sun,
H. Innes,
H. Toyoda,
Q. Xie,
Shuyuan Mo,
V. Sypsa,
I. Guha,
T. Kumada,
J. Niu,
G. Dalekos,
S. Yasuda,
E. Barnes,
J. Lian,
...
V. Suri,
R. Idilman,
S. Barclay,
X. Dou,
T. Berg,
P. Hayes,
J. Flaherty,
Yuanping Zhou,
Zhen-gang Zhang,
M. Buti,
S. Hutchinson,
Ya-bing Guo,
J. Calleja,
Lanjia Lin,
Longfeng Zhao,
Yongpeng Chen,
H. Janssen,
Chaonan Zhu,
Lei Shi,
Xiaoping Tang,
A. Gaggar,
Lai Wei,
J. Jia,
W. Irving,
P. Johnson,
P. Lampertico,
J. Hou
|
7 |
2020 |
7
🐜
|
|
🐜
|
Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen–negative Chinese carriers
10 auth.
J. Hou,
Zhan-Hui Wang,
Jinjun Cheng,
Yu-long Lin,
G. Lau,
Jian Sun,
...
F. Zhou,
J. Waters,
P. Karayiannis,
K. Luo
|
7 |
2001 |
7
🐜
|
|
🐜
|
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct‐acting Antiviral Agents
18 auth.
Cheng Wang,
D. Ji,
J. Chen,
Q. Shao,
Bing Li,
Jialiang Liu,
V. Wu,
A. Wong,
Yudong Wang,
Xiaoyong Zhang,
...
Lei Lu,
Chris L. P. Wong,
S. Tsang,
Zheng Zhang,
Jian Sun,
J. Hou,
Guo-feng Chen,
G. Lau
|
7 |
2017 |
7
🐜
|
|
🐜
|
Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies
8 auth.
Zhanhui Wang,
Jin Zhang,
Hong Yang,
Xiu-hui Li,
S. Wen,
Ya-bing Guo,
...
Jian Sun,
J. Hou
|
7 |
2003 |
7
🐜
|
|
🐬
|
Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection
Shi Liu,
Bin Zhou,
J. Valdes,
Jian Sun,
Haitao Guo
|
7 |
2019 |
7
🐬
|
|
🐜
|
qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients.
17 auth.
Shuoyu Xu,
Yan Wang,
Dean Tai,
Shi Wang,
C. Cheng,
Qiwen Peng,
Jie Yan,
Yongpeng Chen,
Jian Sun,
Xieer Liang,
...
Youfu Zhu,
Jagath Rajapakse,
R. Welsch,
P. So,
A. Wee,
J. Hou,
Hanry Yu
|
7 |
2014 |
7
🐜
|
|
🐜
|
Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues
23 auth.
R. Fan,
Jian Sun,
Q. Yuan,
Q. Xie,
X. Bai,
Q. Ning,
Jun Cheng,
Yanyan Yu,
J. Niu,
G. Shi,
...
Hao Wang,
D. Tan,
M. Wan,
Shijun Chen,
Min Xu,
Xinyue Chen,
Hong Tang,
J. Sheng,
F. Lu,
J. Jia,
Z. Hui,
N. Xia,
J. Hou
|
6 |
2015 |
6
🐜
|
|
🐜
|
High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B.
13 auth.
Shiwu Ma,
Xuan Huang,
Yongyin Li,
L. Tang,
Xiao-feng Sun,
Xiaotao Jiang,
Yue-xin Zhang,
Jian Sun,
Zhi‐hua Liu,
W. Abbott,
...
Yuhong Dong,
N. Naoumov,
J. Hou
|
6 |
2012 |
6
🐜
|
